ML294
ML190
ML190 is a small molecule inhibitor that has been studied for its potential therapeutic effects in various medical conditions. It is primarily known for its role in modulating specific cellular pathways, making it a subject of interest in pharmacological research.
Chemical Properties[edit | edit source]
ML190 is a synthetic compound characterized by its unique chemical structure, which allows it to interact with specific proteins within the cell. The molecular formula of ML190 is C21H18N4O2, and it has a molecular weight of 358.39 g/mol. The compound is typically synthesized through a series of organic reactions, involving the coupling of various chemical intermediates.
Mechanism of Action[edit | edit source]
ML190 functions as an inhibitor of the Wnt signaling pathway, a critical pathway involved in cell proliferation, differentiation, and migration. By inhibiting this pathway, ML190 can potentially regulate abnormal cell growth, making it a candidate for cancer therapy. The compound binds to the Frizzled receptor, preventing the activation of downstream signaling components such as β-catenin.
Pharmacological Effects[edit | edit source]
Studies have shown that ML190 exhibits anti-proliferative effects in various cancer cell lines, including colorectal and breast cancer. The compound has been observed to induce apoptosis, or programmed cell death, in these cells, thereby reducing tumor growth. Additionally, ML190 has been investigated for its effects on stem cell differentiation, given the role of Wnt signaling in stem cell biology.
Clinical Applications[edit | edit source]
While ML190 is still in the preclinical stage of development, its potential applications in oncology are promising. Researchers are exploring its use as a monotherapy or in combination with other chemotherapeutic agents to enhance treatment efficacy. Further studies are needed to evaluate its safety, pharmacokinetics, and optimal dosing regimens in humans.
Research and Development[edit | edit source]
Ongoing research is focused on understanding the broader implications of Wnt pathway inhibition by ML190. This includes its effects on normal tissue homeostasis and potential side effects. Animal models are being used to assess the compound's therapeutic index and to identify any off-target effects that may arise from its use.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
